|
Summary Information: Vir Biotechnology Inc. Common Stock NASDAQ:VIR |
  [email protected] |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: Vir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting SARS-CoV-2, hepatitis B virus, influenza A, human immunodeficiency virus and tuberculosis.
__The following are links to various summary and news pages for __Vir Biotechnology Inc. Common Stock [ VIR ]. __Note: Some Links might not have information for the company. |
|